News

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...
An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...
Kennedy Jr.On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include ...
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...
European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...
Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater than currently accepted.
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...